GlobeNewswire

SolarWinds Adds Assisted Onboarding and Next-Generation Training and Certification Programs, Further Empowering Customers to Fully Optimize Their Software Investments

Dela
  • The Smart Start assisted onboarding program gives customers direct access to product experts and best-practices configuration assistance
  • SolarWinds Academy expands its curriculum and offers full-access subscriptions to customers under active maintenance contracts
  • The updated and expanded SolarWinds Certified Professional program now covers more products and leverages an innovative subscription-based certification program

BARCELONA, Spain, Jan. 29, 2018 (GLOBE NEWSWIRE) -- SolarWinds today unveiled major advancements in its Customer Success program. The enhancements will help speed time-to-value when deploying the company's software to improve performance across networks, systems, and applications. The company launched an innovative assisted onboarding program called Smart Start, which gives customers direct, one-on-one access to experts who help them configure, deploy, and optimize their software to meet business goals. It also unveiled a new generation of its professional training and certification program, SolarWinds Academy.

SolarWinds made these announcements as part of its participation in the annual Cisco Live!® conference beginning today in Barcelona. The new customer success initiatives are the company's latest moves to enable a simple customer and partner experience, from trial, through purchase, and into full deployment.

"Our customers' success drives everything we do - it's in our DNA," said Kevin Bury, SolarWinds senior vice president, customer experience. "The reimagined SolarWinds Academy and SolarWinds Certified Professional® programs, along with Smart Start, our new assisted onboarding program, demonstrate our commitment to helping customers get the most from their investments in our industry-leading IT management software."

Over the past several years, SolarWinds has invested heavily in customer success initiatives. In addition to its vibrant THWACK® user community, the company launched the SolarWinds Success Center, a comprehensive portal offering access to the company's expansive library of how-to videos, product guides, and rich technical articles.

Smart Start to Get Up and Running Quickly
Smart Start is a new offering aimed at helping customers quickly achieve a high return on their software investments based on SolarWinds-recommended best practices. It gives customers and partners one-on-one expert guidance, enabling them to quickly and effectively configure, customize, and optimize their SolarWinds®environments. In particular, the offering focuses on helping customers expertly implement key features according to best practices, tailored to the customer's business need.

"What I most liked about Smart Start was the fact that our deployment was quick and reliable. Working with the Smart Start team for our Patch Manager implementation saved us two to three weeks of implementation time," said William Mead, network administrator/engineer, Parkview Medical Center in Pueblo, Colo.

Smart Start is available immediately for most SolarWinds products. Customers may purchase Smart Start concurrently with their software license, or at a later point in time to address scenarios such as onboarding their new personnel.

SolarWinds Academy: Next-Generation Training and Professional Certification Program
The training and certification program now includes several major enhancements:  First, customers with active maintenance can now access SolarWinds Academy's entire library of courses, which also has been expanded to include a broader set of the company's products. In addition, SolarWinds Academy added sessions to accommodate a wider set of time zones, making it easier for international customers and business partners to participate. The program is growing rapidly, with the number of students more than doubling in 2017.

"A key value-add we provide all our customers under active maintenance is a full access subscription to SolarWinds Academy," explained Cal Smith, director, SolarWinds Academy. "This means customers can access our full library of training content and don't have to budget additional dollars for it."

SolarWinds Academy has also completely revamped its professional certification program, the SolarWinds Certified Professional (SCP), which is available now as annual subscription. The new program builds on the company's extensive global network of certified professionals, and focuses more broadly on enabling the effective use of SolarWinds networking and systems management products. In addition, it now provides access to exclusive SCP webcasts and live events.

SolarWinds collaborated with three of its partners to provide SCP preparation courses - Prosperon, Atlantic Digital, and Loop1. All three companies offer comprehensive classes that prepare examinees with the required knowledge needed to be a successful SCP candidate. 

"The SCP certification clearly separates a SolarWinds administrator among their peers," said Bill Fitzpatrick, chief executive officer, Loop1. "We've seen it firsthand with our clients and in our own recruiting. SCP certification also creates tremendous value for the people and organizations our clients support. We look forward to the new generation of SCP exams to further strengthen the status of being SolarWinds certified."

In 2018, the company will continue to expand the SolarWinds Academy instructor-led online curriculum to cover additional network and system management tools, as well as its SolarWinds Cloud® full-stack monitoring and SolarWinds MSP offerings.

Pricing and Availability
The SolarWinds Certified Professional program is available immediately as a subscription for $200 USD per year and includes one re-take exam. In addition to updates for product enhancements and support, SolarWinds includes a subscription to SolarWinds Academy instructor-led courses for customers under active maintenance.

SolarWinds Smart Start engagements are available immediately, and start at $2,500 depending on the software license purchased. This program gives customers and partners one-on-one expert guidance, enabling them to quickly and effectively configure, customize, and optimize their SolarWinds environments. Customers may contact their sales representative for a quote, or learn more about this global offering here.

*Pricing as of January 29, 2018. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

SolarWinds Academy Smart Start Onboarding Program Certification Success Center

Connect with SolarWinds

THWACK
Twitter®
Facebook®
LinkedIn®

About SolarWinds
SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500® enterprises to small businesses, managed service providers (MSPs), government agencies, and educational institutions. We are committed to focusing exclusively on IT, MSP, and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as the worldwide leader in both network management software and MSP solutions, and is driving similar growth across the full spectrum of IT management software. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks  are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks) of their respective companies.

© 2018 SolarWinds Worldwide, LLC. All rights reserved.

MEDIA CONTACTS:

Nicole Fachet   
Text100
Phone: 212.871.3950
NicoleF@text100.com 
Mark Stanton 
SolarWinds
Phone: 512.682.9692
pr@solarwinds.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum